Evaluation of Stability of Potential Betaadrenolytics in Various Solutions by thin Layer Chromatography and by Kinetics of Hydrolysis

M. Stankovičová 1 , Ž. Bezáková 2 , P. Mokrý 3 , J. Csöllei 3 , M. Pažitná 2 , B. Liptáková 2 , Z. Ševčíková 2 , und S. Dvořáková – Kotlíková 3
  • 1 Comenius University in Bratislava, Faculty of Pharmacy, Department of Pharmaceutical Chemistry, Odbojárov 10, 832 32 Bratislava, Slovak Republic
  • 2 Comenius University in Bratislava, Faculty of Pharmacy, Department of Pharmaceutical Chemistry
  • 3 University of Veterinary and Pharmaceutical Sciences Brno, Faculty of Pharmacy, Institute of Chemical Drugs


The aim of this work is the study of stability and kinetics of hydrolysis of the chosen compounds, derivatives of 2-hydroxy-3-[2-(4-methoxyphenyl)ethylamino]propyl-4- [(alkoxycarbonyl)amino]benzoates and 2-hydroxy-3-[2-(2-methoxyphenyl)ethylamino] propyl-4-[(alkoxycarbonyl)amino]benzoates with potential ultra-short beta-adrenolytic activity. The studied compounds are different in the position of the substituent on the benzene ring in the side chain as well as in the aromatic ring in position 4 with alkyl- (methyl- to butyl-) carbamate. Thin layer chromatography and UV-area spectrophotometry are used in order to establish the stability of these potential pharmaceuticals. The stability studies of the compounds were examined in acidic and alkaline media, in buffers and due oxidation at room and at elevated temperature chromatographically, and Rf values of incipient products and degradation products were detected. Kinetics of acid and base hydrolysis in various solutions at temperatures 80 °C and 100 °C were examined through UV-area spectrophotometry. Kinetic parameters such as rate constant k, half-life period t1/2 and usable life t90 were determined.

Falls das inline PDF nicht korrekt dargestellt ist, können Sie das PDF hier herunterladen.

  • Jackman PG, Iakovidis D, Nero TL, Anavekar NS, Rezmann-Vitti LA, Louis SNS, Mori M, Drummer OH Louis WJ. Synthesis. β-adrenoreceptor pharmacology and toxicology of S-(-)-I-(4-(2-ethoxy)phenoxy)-2-hydroxy-3-(2-(3,4- dimethoxyphenyl)ethylamino)-propane hydrochloride, a short acting β1-specific antagonist. Eur J Med Chem 2002, 37:731-741.

  • Bodor N, Buchwald P. Soft drug design: General principles and recent applications. Med Res 2000, 20:58-101.

  • Kečkéšová S, Sedlárová E. Review of the ultra-short acting beta-adrenergic blockers. (in Slovak) Farm Obzor 2010, 79:3-13.

  • Mokrý P, Macháčková Z, Pavlica J, Csöllei J. Synthesis and physicochemical properties of novel arylkarbonyloxyaminopropanol derivatives, Proceedings of 40th Drug Synthesis and Analysis Conference, Brno 2011, Faculty of Pharmacy University of Veterinary and Pharmaceutical Sciences Brno, ISBN 978 - 80 - 7305 - 596-6.

  • Mokrý P, Zemanová M, Csöllei J, Račanská E, Tumová I. Synthesis and pharmacological evaluation of novel potential ultra-short acting β-blockers. Pharmazie 2003, 58:18-21.

  • Stankovičová M, Bezáková Ž, Pavlíková J, Mažeriková J, Kissová M, Mokrý P, Csöllei J. Study of stability of potential beta-adrenolytics, derivatives of the [(arylcarbonyl)oxy]aminopropanol by kinetics of alkaline hydrolysis. Acta Facult Pharm Univ Comenianae. 2011, 58:72-80.

  • Graham L, Patrick K. An Introduction to Medicinal Chemistry, Fourth Ed. Oxford University Press, 2009:620.

  • Griffith RK. Adrenergics and adrenergic blocking agents. In ABRAHAM D. J.: Burger´s Medicinal Chemistry and Drug Discovery. Vol 6. Nervous System Agents. 6th ed. New York: John Willey & sons, 200:1-39.

  • Watson DG. Pharmaceutical Chemistry. Churchil Livingstone Elsevier. 2011, p. 95.


Zeitschrift + Hefte